208 related articles for article (PubMed ID: 9346290)
21. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
22. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
Crabbe T; Zucker S; Cockett MI; Willenbrock F; Tickle S; O'Connell JP; Scothern JM; Murphy G; Docherty AJ
Biochemistry; 1994 May; 33(21):6684-90. PubMed ID: 7911325
[TBL] [Abstract][Full Text] [Related]
23. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
Itoh Y; Binner S; Nagase H
Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
[TBL] [Abstract][Full Text] [Related]
24. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
Lichte A; Kolkenbrock H; Tschesche H
FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363
[TBL] [Abstract][Full Text] [Related]
25. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.
Knäuper V; Cowell S; Smith B; López-Otin C; O'Shea M; Morris H; Zardi L; Murphy G
J Biol Chem; 1997 Mar; 272(12):7608-16. PubMed ID: 9065415
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix.
Rice A; Banda MJ
Biochemistry; 1995 Jul; 34(28):9249-56. PubMed ID: 7619826
[TBL] [Abstract][Full Text] [Related]
27. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.
Butler GS; Will H; Atkinson SJ; Murphy G
Eur J Biochem; 1997 Mar; 244(2):653-7. PubMed ID: 9119036
[TBL] [Abstract][Full Text] [Related]
28. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.
Sato H; Seiki M
J Biochem; 1996 Feb; 119(2):209-15. PubMed ID: 8882706
[TBL] [Abstract][Full Text] [Related]
29. The 9-kDa N-terminal propeptide domain of MT1-MMP is required for the activation of progelatinase A.
Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
Ann N Y Acad Sci; 1999 Jun; 878():710-2. PubMed ID: 10415815
[No Abstract] [Full Text] [Related]
30. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
[TBL] [Abstract][Full Text] [Related]
31. Gelatinases A and B.
Murphy G; Crabbe T
Methods Enzymol; 1995; 248():470-84. PubMed ID: 7674939
[No Abstract] [Full Text] [Related]
32. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2.
Bigg HF; Shi YE; Liu YE; Steffensen B; Overall CM
J Biol Chem; 1997 Jun; 272(24):15496-500. PubMed ID: 9182583
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms for pro matrix metalloproteinase activation.
Murphy G; Stanton H; Cowell S; Butler G; Knäuper V; Atkinson S; Gavrilovic J
APMIS; 1999 Jan; 107(1):38-44. PubMed ID: 10190278
[TBL] [Abstract][Full Text] [Related]
34. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.
Morgunova E; Tuuttila A; Bergmann U; Isupov M; Lindqvist Y; Schneider G; Tryggvason K
Science; 1999 Jun; 284(5420):1667-70. PubMed ID: 10356396
[TBL] [Abstract][Full Text] [Related]
35. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes.
Atkinson SJ; Crabbe T; Cowell S; Ward RV; Butler MJ; Sato H; Seiki M; Reynolds JJ; Murphy G
J Biol Chem; 1995 Dec; 270(51):30479-85. PubMed ID: 8530478
[TBL] [Abstract][Full Text] [Related]
36. Stepwise activation mechanisms of the precursors of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin).
Nagase H; Suzuki K; Enghild JJ; Salvesen G
Biomed Biochim Acta; 1991; 50(4-6):749-54. PubMed ID: 1666284
[TBL] [Abstract][Full Text] [Related]
37. Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Boon L; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Colau D; Gordon-Alonso M; van der Bruggen P; Stöcker W; Becker-Pauly C; Witters P; Morava E; Jaeken J; Proost P; Opdenakker G
FEBS J; 2019 Mar; 286(5):930-945. PubMed ID: 30422384
[TBL] [Abstract][Full Text] [Related]
38. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
[TBL] [Abstract][Full Text] [Related]
39. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.
Cowell S; Knäuper V; Stewart ML; D'Ortho MP; Stanton H; Hembry RM; López-Otín C; Reynolds JJ; Murphy G
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484
[TBL] [Abstract][Full Text] [Related]
40. Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase.
Cao J; Rehemtulla A; Pavlaki M; Kozarekar P; Chiarelli C
J Biol Chem; 2005 Mar; 280(12):10974-80. PubMed ID: 15637056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]